As 23andMe Struggles, Concerns Surface About Its Genetic Data

A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers.A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers. Genetics and Heredity, Privacy, 23andMe, Wojcicki, Anne, Stocks and Bonds, DNA (Deoxyribonucleic Acid) Read More

Leave a Comment

Your email address will not be published. Required fields are marked *